This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
500mg | $240 | In Stock |
1g | $420 | In Stock |
5g | $1065 | In Stock |
Cat #: V2685 CAS #: 1197376-85-4 Purity ≥ 98%
Description: Capmatinib 2HCl (INCB28060; INC-280; Tabrecta), the dihydrochloride salt of Capmatinib, is an orally bioavailable and ATP-competitive inhibitor of c-MET approved by FDA on August 10, 2022 by the US FDA for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation leading to mesenchymal-epithelial transition (MET) exon 14 skipping, as detected by an FDA-approved test.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 503.38 |
---|---|
Molecular Formula | C24H24Cl2N4O4 |
CAS No. | 1197376-85-4 |
Synonyms | NCB28060 2HCl; INC-280 2HCl; Capmatinib 2HCl;INCB28060 2HCl; INC-280 2HCl; NVP INC280 2HCl; NVP INC-280 2HCl; |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.9866 mL | 9.9329 mL | 19.8657 mL | 39.7314 mL |
5mM | 0.3973 mL | 1.9866 mL | 3.9731 mL | 7.9463 mL |
10mM | 0.1987 mL | 0.9933 mL | 1.9866 mL | 3.9731 mL |
20mM | 0.0993 mL | 0.4966 mL | 0.9933 mL | 1.9866 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.